BeOne Medicines

10/07/2025

New Episode of the Cancer Has No Borders Podcast!

What began as one mother’s heartbreak became a global movement of hope.

In this inspiring episode, Zachary Randles-Friedman sits down with Pat Garcia-Gonzalez, the visionary CEO and co-founder of The Max Foundation who turned the loss of her 17-year-old stepson, Max, into a worldwide mission to ensure cancer patients in low-resource countries can access lifesaving treatment.

Pat and her team have helped more than 100,000 patients across 80+ countries—delivering not just medicine, but dignity, education, and hope to families facing impossible odds.

Listen now:

YouTube: https://ow.ly/pF1g50X7VcK
Apple: https://ow.ly/NSXZ50X7VcI
Spotify: https://ow.ly/oaEX50X7VcJ
Amazon: https://ow.ly/slgk50X7VcG

Learn more about The Max Foundation at https://ow.ly/fuH350X7VcH

In this powerful episode of The Cancer Has No Borders podcast, host Zach Randles-Friedman sits down with Pat García-González, co-founder and CEO of The Max F...

10/03/2025

At BeOne, our commitment to patients goes beyond innovation. We believe in the power of partnerships to elevate patient voices, expand access, and co-create solutions that improve lives.

This , we’re spotlighting key patient advocacy partners, including Living Beyond Breast Cancer, Tigerlily Foundation, and Susan G. Komen, alongside the broader community working every day to support and empower people impacted by breast cancer.

Let’s learn, share, and advocate together.

09/30/2025

As Blood Cancer Awareness Month comes to a close, we continue to honor the patients, families, caregivers, advocates, and clinicians who inspire us every day.

At BeOne, our commitment doesn’t end in September. From advancing science with purpose, to expanding access across geographies, to keeping patients at the center of all we do — we are working together to help close the gaps in blood cancer care.

Watch this short video featuring our leaders from around the world, reflecting on how we’re making an impact — today, tomorrow, and every day.

09/29/2025

We are honored to support Cancer Support Community’s pre-conference at the Native Cancer Conference, hosted by the American Indian Cancer Foundation. This important gathering shines a light on access, quality of care, and culturally grounded solutions to address cancer inequities in the Native American community. These conversations are vital to building trust, expanding access, and ensuring that every patient has the opportunity for quality care.

We’re thrilled to partner with the American Indian Cancer Foundation to offer a free pre-conference to their annual Native Cancer Conference. Hosted at the Radisson Blu Mall of America in Minnesota on Monday, November 3rd, the pre-conference will feature a multi-disciplinary group of leaders and experts discussing crucial concerns including access and payment models with quality of care as a central theme.

We encourage all interested in attending the pre-conference and the Native Cancer Conference to follow to visit the link below to learn more.

We thank BeOne Medicines for their support of CSC’s pre-conference and AstraZeneca for their support of the .

betterunite.com/nativecancerconference

09/25/2025

Meet Vanessa Morais, Quality Senior Manager, who’s personal experience with cancer provides a unique perspective within her role.

We’re proud to be part of , who takes a stand against cancer and strives to challenge the status quo to deliver science previously thought to be impossible.

Interested in joining us? Visit https://ow.ly/pWFP50X29Cr.

09/24/2025

For CLL patients, the phrase 'watch and wait' can create anxiety and uncertainty during active monitoring. At BeOne, we are dedicated to ensuring that patients with Chronic Lymphocytic Leukemia (CLL) and their caregivers have access to clear and credible information.

Collaborating with our panel of experts, including Jan Geissler, Christina Karamanidou, Jana Pelouchova, Lydia Scarfo & Peter Haggert, we came together to tackle the pressing challenges faced by the CLL community. As key contributors to the CLL Call-To-Action Report, the panel explored critical areas of unmet need and innovative approaches to care, placing a strong emphasis on the emotional and practical support required to navigate active monitoring.

Watch the full discussion to learn how you can take actionable steps to enhance the lives of people living with CLL: https://youtu.be/5D2zaDc2ISc

09/17/2025

"When my patients hear the word 'cancer,' the shutters come down."

For Dr. Kennedy, a dedicated hematologist, effective communication is key to helping patients navigate the complexities of Chronic Lymphocytic Leukemia (CLL). The anxiety felt during CLL diagnosis can be significantly decreased when patients have a clear understanding of CLL and the support available to them.

"Without good, trusted information, patients can become overwhelmed with worry." How healthcare providers present and discuss information greatly affects how patients feel when they leave the consultation room—either empowered, ready to take action and thrive, or worried, scared, and uncertain about their future.

Discover Dr. Kennedy's insights gained from working with CLL patients and discover the Call-to-Action Report, developed in partnership with CLL Advocates Network, to highlight the unmet needs in their care: https://ow.ly/8vHF50WXO6x

09/12/2025

We look forward to supporting Lymphoma Research Foundation's upcoming Educational Forum on Lymphoma, happening virtually September 20–21.

This two-day program is designed to give patients and care partners access to expert guidance on the diagnosis and treatment of lymphoma and , the latest research, and support for every step of the journey.

Learn more and register here: https://lymphoma.org/resources/educationresources/programs/edforum

09/12/2025

We are back at international CLL Horizons Conference with a significant impact: the launch of the Call-to-Action Report developed in partnership with CLL Advocates Network. This report addresses critical gaps for Chronic Lymphocytic Leukemia (CLL) patients in active monitoring.

Unlike other cancers requiring immediate treatment, many CLL patients enter a prolonged observation period called active monitoring that's emotionally and psychologically complex. A key recommendation of the Call-to-Action report is to enhance communication between patients and healthcare providers.

Closing this communication gap formed the focus of BeOne’s interactive session at CLL Horizons, attended by patients, patient advocates and physicians from six continents. Hematologist Dr. Ben Kennedy and CLL patient advocate Johannes Foerner demonstrated effective communication strategies in a live role-play

Deepening trust and understanding in the consultation room are essential for better decision-making and improved patient outcomes. Dr. Brian Koffman facilitated an interactive discussion with session participants to collaboratively explore practical steps to achieve just that.

BeOne was proud to be part of CLL Horizons which provided a platform for meaningful dialogue and strategic advancement in holistic CLL care.

For more on the Call-to-Action report and the expert recommendations to empower CLL patients, visit: https://www.clladvocates.net/program/cll-active-monitoring-cta/

09/11/2025

Behind every advance in blood cancer care are the patients, families, and researchers who make progress possible.

In our latest Cancer Has No Borders podcast, Lynn Godfrey from Blood Cancer United talks about some of the challenges patients face, and how representation in trials and early diagnosis can change the story for those living with blood cancer.

Listen now on your favorite podcast platform or watch the full interview on YouTube.

YouTube: https://youtu.be/Pn9eiRMN66A?si=DMFyM3MY7V0hT4YU
Apple: https://podcasts.apple.com/us/podcast/episode-10-lynn-godfrey-chief-constituent-experience/id1784166790?i=1000726200854
Spotify: https://open.spotify.com/episode/2LSVA5x7dTDrwsVn8w8wbh?si=0940e19e007b4064

Learn more about Blood Cancer United: https://bloodcancerunited.org/

09/10/2025

BeOne is proud to stand with Blood Cancer United as walks kick off nationwide this month during and continue through November.

is at the heart of everything we do. As the National Presenting Sponsor of Survivorship and Hope, we’re honored to help bring light to the darkness of cancer by supporting vital research, patient services, and advocacy for patients and families impacted by blood cancer.

💡Each lantern carried is a symbol of hope. Each step brings us closer to a future free from disease. Find a walk near you and join us: https://ow.ly/5z9V50WUvHB

09/10/2025

September is (BCAM) – and the Lymphoma Research Foundation stands apart as the nation’s only nonprofit dedicated exclusively to lymphoma, the most common type of blood cancer.

During - and all year long - we’re proud to be not just a part of the lymphoma conversation, but the leader in it.

Learn more about our dedication to the lymphoma community and our Blood Cancer Awareness Month celebrations in our latest blog: https://lymphoma.org/news/blood-cancer-awareness-month-standing-together-leading-the-lymphoma-community/